文献速递妇科生殖医学

患者所在地与妇科或乳腺癌女性生育力保存可及性的差异

Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer.
PubMed 文献 · Obstet Gynecol · 2024-04-05

基于加州癌症登记等关联数据的队列研究,纳入2000年1月至2015年12月诊断的18-45岁早期妇科癌症或I-III期乳腺癌患者。居住地距妇科肿瘤或生育诊所越远,接受保留生育治疗的概率越低;社区健康指数评分越高,接受保留生育治疗和辅助生殖技术的概率越高。

要点

  • 居住地距妇科肿瘤诊所越远,保留生育治疗概率越低(Q4 OR 0.72)。
  • 居住地距生育诊所越远,保留生育治疗概率越低(Q4 OR 0.67)。
  • 社区健康指数最高四分位者保留生育治疗概率更高(OR 1.66)。

核心结论

  • 地理差异影响妇科或乳腺癌女性接受保留生育治疗和辅助生殖技术的比例。

研究设计与样本

  • 队列研究,使用加州癌症登记、加州州级健康规划与发展办公室及辅助生殖技术学会的关联数据,纳入2000年1月至2015年12月诊断的18-45岁早期宫颈癌、子宫内膜癌或卵巢癌或I-III期乳腺癌患者。

主要发现

  • 共识别7612例妇科癌症女性和35992例乳腺癌女性,所有患者中257例(0.6%)接受了辅助生殖技术。
  • 妇科癌症患者中1676例(22.0%)接受了保留生育治疗。
  • 距妇科肿瘤诊所距离Q2的OR 0.76(95%CI 0.63-0.93,P=.007),Q4的OR 0.72(95%CI 0.56-0.94,P=.016);距生育诊所距离Q3的OR 0.79(95%CI 0.65-0.97,P=.025),Q4的OR 0.67(95%CI 0.52-0.88,P=.004)。
  • 加州健康场所指数最高两个百分位组(51-100百分位)接受保留生育治疗的OR分别为1.29(95%CI 1.06-1.57,P=.01)和1.66(95%CI 1.35-2.04,P=.001)。
  • 加州健康场所指数与辅助生殖技术的关系更明显:Q2 OR 1.9(95%CI 0.99-3.64,P=.05),Q3 OR 2.86(95%CI 1.54-5.33,P<.001),Q4 OR 3.41(95%CI 1.83-6.35,P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of geographic factors on fertility-sparing treatment or assisted reproductive technology (ART) utilization among women with gynecologic or breast cancers. METHODS: We conducted a cohort study of reproductive-aged patients (18-45 years) with early-stage cervical, endometrial, or ovarian cancer or stage I-III breast cancer diagnosed between January 2000 and December 2015 using linked data from the California Cancer Registry, the California Office of Statewide Health Planning and Development, and the Society for Assisted Reproductive Technology. Generalized linear mixed models were used to evaluate associations between distance from fertility and gynecologic oncology clinics, as well as California Healthy Places Index score (a Census-level composite community health score), and ART or fertility-sparing treatment receipt. RESULTS: We identified 7,612 women with gynecologic cancer and 35,992 women with breast cancer. Among all patients, 257 (0.6%) underwent ART. Among patients with gynecologic cancer, 1,676 (22.0%) underwent fertility-sparing treatment. Stratified by quartiles, residents who lived at increasing distances from gynecologic oncology or fertility clinics had decreased odds of undergoing fertility-sparing treatment (gynecologic oncology clinics: Q2, odds ratio [OR] 0.76, 95% CI, 0.63-0.93, P =.007; Q4, OR 0.72, 95% CI, 0.56-0.94, P =.016) (fertility clinics: Q3, OR 0.79, 95% CI, 0.65-0.97, P =.025; Q4, OR 0.67, 95% CI, 0.52-0.88, P =.004), whereas this relationship was not observed among women who resided within other quartiles (gynecologic oncology clinics: Q3, OR 0.81 95% CI, 0.65-1.01, P =.07; fertility clinics: Q2, OR 0.87 95% CI, 0.73-1.05, P =.15). Individuals who lived in communities with the highest (51 st -100 th percentile) California Healthy Places Index scores had greater odds of undergoing fertility-sparing treatment (OR 1.29, 95% CI, 1.06-1.57, P =.01; OR 1.66, 95% CI, 1.35-2.04, P =.001, respectively). The relationship between California Healthy Places Index scores and ART was even more pronounced (Q2 OR 1.9, 95% CI, 0.99-3.64, P =.05; Q3 OR 2.86, 95% CI, 1.54-5.33, P <.001; Q4 OR 3.41, 95% CI, 1.83-6.35, P <.001). CONCLUSION: Geographic disparities affect fertility-sparing treatment and ART rates among women with gynecologic or breast cancer. By acknowledging geographic factors, health care systems can ensure equitable access to fertility-preservation services.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kanbergs A, Jorgensen K, Agusti N, et al. Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer. Obstet Gynecol. 2024. PMID: 38574368. doi:10.1097/AOG.0000000000005570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。